DUBLIN, Ireland, Nov. 5, 2008 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR), an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award for its Almerol (formerly known as MER-103) product.
